Zoledronic acid and angiogenesis

被引：4

作者：

Ferretti, Gianluigi ^{[1
]}

Fabi, Alessandra ^{[1
]}

Carlini, Paolo ^{[1
]}

Papaldo, Paola ^{[1
]}

Felici, Alessandra ^{[1
]}

Tornao, Silverio ^{[1
]}

Cognetti, Francesco ^{[1
]}

机构：

[1] Regina Elena Inst Canc Res, Div Med Oncol A, Rome, Italy

来源：

CLINICAL CANCER RESEARCH | 2007年 / 13卷 / 22期

关键词：

D O I：

10.1158/1078-0432.CCR-07-4036

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6850 / 6850

页数：1

共 5 条

[1] Bisphosphonates and cancer-induced bone disease:: Beyond their antiresorptive activity [J].

Clézardin, P ;

Ebetino, FH ;

Fournier, PGJ .

CANCER RESEARCH, 2005, 65 (12) :4971-4974

[2] Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis [J].

Ferretti, Gianluigi ;

Fabi, Alessandra ;

Carlini, Paolo ;

Papaldo, Paola ;

Felici, Alessandra ;

Cognetti, Francesco .

BONE, 2007, 41 (01) :155-156

[3] An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis [J].

Giraudo, E ;

Inoue, M ;

Hanahan, D .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (05) :623-633

[4] Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand [J].

Heissig, B ;

Hattori, K ;

Dias, S ;

Friedrich, M ;

Ferris, B ;

Hackett, NR ;

Crystal, RG ;

Besmer, P ;

Lyden, D ;

Moore, MAS ;

Werb, Z ;

Rafii, S .

CELL, 2002, 109 (05) :625-637

[5] Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients [J].

Santini, Daniele ;

Vincenzi, Bruno ;

Galluzzo, Sara ;

Battistoni, Fabrizio ;

Rocci, Laura ;

Venditti, Olga ;

Schiavon, Gaia ;

Angeletti, Silvia ;

Uzzalli, Federica ;

Caraglia, Michele ;

Dicuonzo, Giordano ;

Tonini, Giuseppe .

CLINICAL CANCER RESEARCH, 2007, 13 (15) :4482-4486

← 1 →